Clin2
NCT05709483Possibly a fitRecruiting

Aspirin plan test to predict who avoids preeclampsia

Preeclampsia

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study looks for blood markers that may predict whether low-dose aspirin will “work” to prevent preeclampsia in a next pregnancy. It may help improve which patients benefit most from aspirin and guide safer prevention in future pregnancies.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
130 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are age 18 to 45
  • You previously had preeclampsia and then became pregnant again
  • In your next pregnancy, you took 81 mg aspirin before 16 weeks and took it most days (at least 80% by your report)
  • Your next pregnancy went past 20 weeks
  • Before a blood test, you can avoid non-prescription NSAID pain relievers for 1 week (unless your doctor says otherwise)
  • You do not have certain health issues like bleeding disorders, major kidney or liver problems, a past aspirin allergy, or a history of hemorrhagic stroke

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06826859Recruiting· Phase 1/Phase 2
Daily aspirin vs split dosing to prevent preeclampsia

This study compares taking a daily low-dose aspirin (a single pill) versus splitting the same dose into two smaller pills many hours apart to see which way better prevents preeclampsia in pregnant people who are at higher risk.

Philadelphia, Pennsylvania
NCT07665853Not yet recruiting· Phase 3
Aspirin to prevent preeclampsia in high-risk pregnancies

This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.

Vienna
NCT07779057Recruiting· Phase 4
Aspirin dose to prevent preeclampsia

This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.

Multan, Punjab Province
NCT06802861Recruiting
Aspirin metabolism in pregnant women at risk of pre-eclampsia

This study looks at how pregnant women at risk of pre-eclampsia process aspirin and how it affects their metabolism. Researchers will use blood and urine tests, along with body measurements and surveys, to learn more about how aspirin can help prevent pre-eclampsia.

Knoxville, Tennessee
NCT07614893Not yet recruiting
Testing alerts to help doctors prescribe aspirin for pregnancy safety

This trial tests whether sending reminders to doctors helps them prescribe low-dose aspirin to pregnant patients at higher risk of preeclampsia (a serious pregnancy condition). Aspirin early in pregnancy may help prevent preeclampsia if you have risk factors.

Boston, Massachusetts
NCT06168461Recruiting· Early Phase 1
Can daily aspirin help after preeclampsia?

This study tests whether taking a low-dose aspirin every day can help improve blood vessel health in people who had preeclampsia within the past 5 years. The goal is to see if aspirin can lower the risk of future heart problems.

Iowa City, Iowa

Hear when a new Preeclampsia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.